CD74 supports accumulation and function of regulatory T cells in tumors.
Saved in:
| Title: | CD74 supports accumulation and function of regulatory T cells in tumors. |
|---|---|
| Authors: | Bonnin E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Rodrigo Riestra M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Marziali F; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Mena Osuna R; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Denizeau J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Maurin M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Saez JJ; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Jouve M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Bonté PE; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Richer W; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Nevo F; Egle Therapeutics, Paris, France., Lemoine S; Egle Therapeutics, Paris, France., Girard N; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Paris Saclay University, UVSQ, Versailles, France.; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Lefevre M; Pathology Department, Institut Mutualiste Montsouris, Paris, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Vincent-Salomon A; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Research University, Institut Curie Research Center, Paris, France., Moreau HD; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Sedlik C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Hivroz C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Lennon-Duménil AM; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Tosello Boari J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr., Piaggio E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Egle Therapeutics, Paris, France. eliane.piaggio@curie.fr. |
| Source: | Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3749. Date of Electronic Publication: 2024 May 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38702311 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD74 supports accumulation and function of regulatory T cells in tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bonnin+E%22">Bonnin E</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rodrigo+Riestra+M%22">Rodrigo Riestra M</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Marziali+F%22">Marziali F</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mena+Osuna+R%22">Mena Osuna R</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Denizeau+J%22">Denizeau J</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Maurin+M%22">Maurin M</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Saez+JJ%22">Saez JJ</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jouve+M%22">Jouve M</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bonté+PE%22">Bonté PE</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Richer+W%22">Richer W</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nevo+F%22">Nevo F</searchLink>; Egle Therapeutics, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lemoine+S%22">Lemoine S</searchLink>; Egle Therapeutics, Paris, France.<br /><searchLink fieldCode="AU" term="%22Girard+N%22">Girard N</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Paris Saclay University, UVSQ, Versailles, France.; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lefevre+M%22">Lefevre M</searchLink>; Pathology Department, Institut Mutualiste Montsouris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Borcoman+E%22">Borcoman E</searchLink>; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vincent-Salomon+A%22">Vincent-Salomon A</searchLink>; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Baulande+S%22">Baulande S</searchLink>; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Moreau+HD%22">Moreau HD</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sedlik+C%22">Sedlik C</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hivroz+C%22">Hivroz C</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lennon-Duménil+AM%22">Lennon-Duménil AM</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tosello+Boari+J%22">Tosello Boari J</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr.<br /><searchLink fieldCode="AU" term="%22Piaggio+E%22">Piaggio E</searchLink>; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Egle Therapeutics, Paris, France. eliane.piaggio@curie.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3749. <i>Date of Electronic Publication: </i>2024 May 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38702311 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-47981-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3749 Titles: – TitleFull: CD74 supports accumulation and function of regulatory T cells in tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bonnin E – PersonEntity: Name: NameFull: Rodrigo Riestra M – PersonEntity: Name: NameFull: Marziali F – PersonEntity: Name: NameFull: Mena Osuna R – PersonEntity: Name: NameFull: Denizeau J – PersonEntity: Name: NameFull: Maurin M – PersonEntity: Name: NameFull: Saez JJ – PersonEntity: Name: NameFull: Jouve M – PersonEntity: Name: NameFull: Bonté PE – PersonEntity: Name: NameFull: Richer W – PersonEntity: Name: NameFull: Nevo F – PersonEntity: Name: NameFull: Lemoine S – PersonEntity: Name: NameFull: Girard N – PersonEntity: Name: NameFull: Lefevre M – PersonEntity: Name: NameFull: Borcoman E – PersonEntity: Name: NameFull: Vincent-Salomon A – PersonEntity: Name: NameFull: Baulande S – PersonEntity: Name: NameFull: Moreau HD – PersonEntity: Name: NameFull: Sedlik C – PersonEntity: Name: NameFull: Hivroz C – PersonEntity: Name: NameFull: Lennon-Duménil AM – PersonEntity: Name: NameFull: Tosello Boari J – PersonEntity: Name: NameFull: Piaggio E IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 05 Text: 2024 May 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |